Risk of hepatitis B reactivation and the role of novel agents and stem-cell transplantation in multiple myeloma patients with hepatitis B virus (HBV) infection-Reference-Cited by-同舟云学术

Risk of hepatitis B reactivation and the role of novel agents and stem-cell transplantation in multiple myeloma patients with hepatitis B virus (HBV) infection

Published:2012-02 Issue:2 Volume:23 Page:421-426
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Mya D.H.T.,Han S.T.,Linn Y.C.,Hwang W.Y.K.,Goh Y.T.,Tan D.C.L.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/23/2/421/553087/mdr142.pdf

Reference36 articles.

1. Severe hepatitis related to chemotherapy in hepatitis B virus carriers with hematologic malignancies. Survey in Japan, 1987–91;Nakamura;Cancer,1996

2. Frequency of hepatitis B virus reactivation in cancer patient undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors;Yeo;J Med Virol,2000

3. Hepatitis B virus carriers in the treatment of malignant lymphoma: an epidemiological study in Japan;Kumagai;Ann Oncol,1997

4. Chemotherapy and bone marrow transplantation for cancer patients who are also chronic hepatitis B carriers;Liang;J Clin Oncol,1999

5. Hepatitis B infection in patients with lymphomas;Liang;Hematol Oncol,1990

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies in the targeted therapy era;World Journal of Gastroenterology;2023-09-07

2. Executive summary of consensus clinical practice guidelines for the prevention of infection in patients with multiple myeloma;Internal Medicine Journal;2023-07-12

3. Autologous hematopoietic cell transplantation for myeloma patients with hepatitis B virus or hepatitis C virus in the era of novel agents;Bone Marrow Transplantation;2022-03-24

4. Prevention of hepatitis B reactivation in patients requiring chemotherapy and immunosuppressive therapy;World Journal of Clinical Cases;2021-07-26

5. Clearance of HBsAg in a patient with familial multiple myeloma after a bortezomib-based regimen combined with anti-HBV drug;Medicine;2020-10-02